Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Hangzhou, Zhejiang, China.
Stem Cell Res Ther. 2024 May 31;15(1):155. doi: 10.1186/s13287-024-03768-3.
In the past decade, intestinal organoid technology has paved the way for reproducing tissue or organ morphogenesis during intestinal physiological processes in vitro and studying the pathogenesis of various intestinal diseases. Intestinal organoids are favored in drug screening due to their ability for high-throughput in vitro cultivation and their closer resemblance to patient genetic characteristics. Furthermore, as disease models, intestinal organoids find wide applications in screening diagnostic markers, identifying therapeutic targets, and exploring epigenetic mechanisms of diseases. Additionally, as a transplantable cellular system, organoids have played a significant role in the reconstruction of damaged epithelium in conditions such as ulcerative colitis and short bowel syndrome, as well as in intestinal material exchange and metabolic function restoration. The rise of interdisciplinary approaches, including organoid-on-chip technology, genome editing techniques, and microfluidics, has greatly accelerated the development of organoids. In this review, VOSviewer software is used to visualize hot co-cited journal and keywords trends of intestinal organoid firstly. Subsequently, we have summarized the current applications of intestinal organoid technology in disease modeling, drug screening, and regenerative medicine. This will deepen our understanding of intestinal organoids and further explore the physiological mechanisms of the intestine and drug development for intestinal diseases.
在过去的十年中,肠类器官技术为体外重现肠道生理过程中的组织或器官形态发生以及研究各种肠道疾病的发病机制铺平了道路。肠类器官因其能够进行高通量的体外培养并且更接近患者的遗传特征而在药物筛选中受到青睐。此外,作为疾病模型,肠类器官在筛选诊断标志物、确定治疗靶点以及探索疾病的表观遗传机制方面得到了广泛应用。此外,作为可移植的细胞系统,类器官在溃疡性结肠炎和短肠综合征等情况下受损上皮的重建以及肠道物质交换和代谢功能的恢复中发挥了重要作用。包括类器官芯片技术、基因组编辑技术和微流控技术在内的跨学科方法的兴起极大地加速了类器官的发展。在本综述中,首先使用 VOSviewer 软件可视化肠类器官的热门共引期刊和关键词趋势。随后,我们总结了肠类器官技术在疾病建模、药物筛选和再生医学中的当前应用。这将加深我们对肠类器官的理解,并进一步探索肠道的生理机制和肠道疾病的药物开发。